Alloy Therapeutics Inc. ("Alloy"), a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug ...

Alloy Therapeutics Inc., a biotechnology ecosystem company, has joined forces with Pfizer Inc., to develop a new platform ...

Privately-held Alloy Therapeutics has announced a new multi-year collaboration with Pfizer to develop a bespoke platform that ...

After an apparent accidental early release, Pfizer has revealed phase 1 data showing its investigational candidate, alongside ...

Pfizer (NYSE:PFE) has entered into a multi-year collaboration with Alloy Therapeutics to develop a new antibody discovery platform. Under the deal, Alloy will receive an upfront payment from Pfizer ...

Smith System, a global leader in driver safety management, has acquired Brightmile, a cutting-edge driver behavior analytics solution. This strategic acquisition enhances Smith System's ability to ...

Tempus AI, Inc. , a leader in artificial intelligence and precision medicine, today announced they will report financial results for the fourth quarter and full year 2024 on Monday, February 24, 2025.

The Series B round was co-led by Samsara BioCapital and Enavate Sciences, with participation from Pfizer Ventures ... supported by its collaboration with Alloy Therapeutics to develop precision ...

With a forward P/E ratio of 5.79 and a PEG ratio of 0.05, BioNTech played a huge part in formulating the BioNTech-Pfizer vaccine ... supplies ferro-alloys; along with processes ferrous and ...

The Series B round was co-led by Samsara BioCapital and Enavate Sciences, with participation from Pfizer Ventures ... s trajectory is further supported by its collaboration with Alloy Therapeutics to ...

Explore how Medicare drug price negotiations under the Inflation Reduction Act could evolve with the Trump administration.

While presenting at the JP Morgan Healthcare Conference, Pfizer Inc. (NYSE:PFE) Albert Bourla, Chairman and CEO, said, “I think we did significant transformative changes in Pfizer.” ...